| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |